aluates Reports

$ 0.0

Automative

Global Gene Therapy for Ovarian Cancer Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-8V13535

Global Gene Therapy for Ovarian Cancer Market Research Report 2023

BUY CHAPTERS

Global Gene Therapy for Ovarian Cancer Market Research Report 2025

Code: QYRE-Auto-8V13535

Report

September 2025

Pages:68

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gene Therapy for Ovarian Cancer Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gene Therapy for Ovarian Cancer Market

The global market for Gene Therapy for Ovarian Cancer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor, and stromal ovarian tumor are some of the less common types. It is the seventh most common cancer in women globally and 18th most common cancer overall. The ovarian cancer immunotherapies market has already got some commercially successful chemotherapy products. However, chemotherapy often involves a combination of two or more drugs, given intravenously every 3-4 weeks, and mostly associated with long-lasting side/adverse effects. Various studies have shown that chemotherapy can damage the blood-producing cells of the bone marrow, resulting in blood-related complications.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gene Therapy for Ovarian Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy for Ovarian Cancer.

The Gene Therapy for Ovarian Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy for Ovarian Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapy for Ovarian Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Therapy for Ovarian Cancer Market Report

Report Metric	Details
Report Name	Gene Therapy for Ovarian Cancer Market
CAGR	5%
Segment by Type	Intravenous Intratumoral Intraperitoneal
Segment by Application	Ovarian Cancer (Unspecified) Recurrent Ovarian Epithelial Cancer Platinum-Resistant Ovarian Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takara Bio, VBL Therapeutics, CELSION, Targovax
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy for Ovarian Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Therapy for Ovarian Cancer Market report?

Ans: The main players in the Gene Therapy for Ovarian Cancer Market are Takara Bio, VBL Therapeutics, CELSION, Targovax

What are the Application segmentation covered in the Gene Therapy for Ovarian Cancer Market report?

Ans: The Applications covered in the Gene Therapy for Ovarian Cancer Market report are Ovarian Cancer (Unspecified), Recurrent Ovarian Epithelial Cancer, Platinum-Resistant Ovarian Cancer

What are the Type segmentation covered in the Gene Therapy for Ovarian Cancer Market report?

Ans: The Types covered in the Gene Therapy for Ovarian Cancer Market report are Intravenous, Intratumoral, Intraperitoneal

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Intravenous

1.2.3 Intratumoral

1.2.4 Intraperitoneal

1.3 Market by Application

1.3.1 Global Gene Therapy for Ovarian Cancer Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Ovarian Cancer (Unspecified)

1.3.3 Recurrent Ovarian Epithelial Cancer

1.3.4 Platinum-Resistant Ovarian Cancer

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapy for Ovarian Cancer Market Perspective (2020-2031)

2.2 Global Gene Therapy for Ovarian Cancer Growth Trends by Region

2.2.1 Global Gene Therapy for Ovarian Cancer Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gene Therapy for Ovarian Cancer Historic Market Size by Region (2020-2025)

2.2.3 Gene Therapy for Ovarian Cancer Forecasted Market Size by Region (2026-2031)

2.3 Gene Therapy for Ovarian Cancer Market Dynamics

2.3.1 Gene Therapy for Ovarian Cancer Industry Trends

2.3.2 Gene Therapy for Ovarian Cancer Market Drivers

2.3.3 Gene Therapy for Ovarian Cancer Market Challenges

2.3.4 Gene Therapy for Ovarian Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue

3.1.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue (2020-2025)

3.1.2 Global Gene Therapy for Ovarian Cancer Revenue Market Share by Players (2020-2025)

3.2 Global Gene Therapy for Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gene Therapy for Ovarian Cancer Revenue

3.4 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio

3.4.1 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Ovarian Cancer Revenue in 2024

3.5 Global Key Players of Gene Therapy for Ovarian Cancer Head office and Area Served

3.6 Global Key Players of Gene Therapy for Ovarian Cancer, Product and Application

3.7 Global Key Players of Gene Therapy for Ovarian Cancer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy for Ovarian Cancer Breakdown Data by Type

4.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Type (2020-2025)

4.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2026-2031)

5 Gene Therapy for Ovarian Cancer Breakdown Data by Application

5.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Application (2020-2025)

5.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gene Therapy for Ovarian Cancer Market Size (2020-2031)

6.2 North America Gene Therapy for Ovarian Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gene Therapy for Ovarian Cancer Market Size by Country (2020-2025)

6.4 North America Gene Therapy for Ovarian Cancer Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Therapy for Ovarian Cancer Market Size (2020-2031)

7.2 Europe Gene Therapy for Ovarian Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2020-2025)

7.4 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size (2020-2031)

8.2 Asia-Pacific Gene Therapy for Ovarian Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2020-2025)

8.4 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Therapy for Ovarian Cancer Market Size (2020-2031)

9.2 Latin America Gene Therapy for Ovarian Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2020-2025)

9.4 Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size (2020-2031)

10.2 Middle East & Africa Gene Therapy for Ovarian Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2020-2025)

10.4 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takara Bio

11.1.1 Takara Bio Company Details

11.1.2 Takara Bio Business Overview

11.1.3 Takara Bio Gene Therapy for Ovarian Cancer Introduction

11.1.4 Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2020-2025)

11.1.5 Takara Bio Recent Development

11.2 VBL Therapeutics

11.2.1 VBL Therapeutics Company Details

11.2.2 VBL Therapeutics Business Overview

11.2.3 VBL Therapeutics Gene Therapy for Ovarian Cancer Introduction

11.2.4 VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2020-2025)

11.2.5 VBL Therapeutics Recent Development

11.3 CELSION

11.3.1 CELSION Company Details

11.3.2 CELSION Business Overview

11.3.3 CELSION Gene Therapy for Ovarian Cancer Introduction

11.3.4 CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2020-2025)

11.3.5 CELSION Recent Development

11.4 Targovax

11.4.1 Targovax Company Details

11.4.2 Targovax Business Overview

11.4.3 Targovax Gene Therapy for Ovarian Cancer Introduction

11.4.4 Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2020-2025)

11.4.5 Targovax Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Intravenous

Table 3. Key Players of Intratumoral

Table 4. Key Players of Intraperitoneal

Table 5. Global Gene Therapy for Ovarian Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gene Therapy for Ovarian Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Gene Therapy for Ovarian Cancer Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Gene Therapy for Ovarian Cancer Market Share by Region (2020-2025)

Table 9. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Gene Therapy for Ovarian Cancer Market Share by Region (2026-2031)

Table 11. Gene Therapy for Ovarian Cancer Market Trends

Table 12. Gene Therapy for Ovarian Cancer Market Drivers

Table 13. Gene Therapy for Ovarian Cancer Market Challenges

Table 14. Gene Therapy for Ovarian Cancer Market Restraints

Table 15. Global Gene Therapy for Ovarian Cancer Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Gene Therapy for Ovarian Cancer Market Share by Players (2020-2025)

Table 17. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2024)

Table 18. Ranking of Global Top Gene Therapy for Ovarian Cancer Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Gene Therapy for Ovarian Cancer Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Gene Therapy for Ovarian Cancer, Headquarters and Area Served

Table 21. Global Key Players of Gene Therapy for Ovarian Cancer, Product and Application

Table 22. Global Key Players of Gene Therapy for Ovarian Cancer, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Gene Therapy for Ovarian Cancer Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2020-2025)

Table 26. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2026-2031)

Table 28. Global Gene Therapy for Ovarian Cancer Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2020-2025)

Table 30. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2026-2031)

Table 32. North America Gene Therapy for Ovarian Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Gene Therapy for Ovarian Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Gene Therapy for Ovarian Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Gene Therapy for Ovarian Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Gene Therapy for Ovarian Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 47. Takara Bio Company Details

Table 48. Takara Bio Business Overview

Table 49. Takara Bio Gene Therapy for Ovarian Cancer Product

Table 50. Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2020-2025) & (US$ Million)

Table 51. Takara Bio Recent Development

Table 52. VBL Therapeutics Company Details

Table 53. VBL Therapeutics Business Overview

Table 54. VBL Therapeutics Gene Therapy for Ovarian Cancer Product

Table 55. VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2020-2025) & (US$ Million)

Table 56. VBL Therapeutics Recent Development

Table 57. CELSION Company Details

Table 58. CELSION Business Overview

Table 59. CELSION Gene Therapy for Ovarian Cancer Product

Table 60. CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2020-2025) & (US$ Million)

Table 61. CELSION Recent Development

Table 62. Targovax Company Details

Table 63. Targovax Business Overview

Table 64. Targovax Gene Therapy for Ovarian Cancer Product

Table 65. Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2020-2025) & (US$ Million)

Table 66. Targovax Recent Development

Table 67. Research Programs/Design for This Report

Table 68. Key Data Information from Secondary Sources

Table 69. Key Data Information from Primary Sources

Table 70. Authors List of This Report

List of Figures

Figure 1. Gene Therapy for Ovarian Cancer Picture

Figure 2. Global Gene Therapy for Ovarian Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gene Therapy for Ovarian Cancer Market Share by Type: 2024 VS 2031

Figure 4. Intravenous Features

Figure 5. Intratumoral Features

Figure 6. Intraperitoneal Features

Figure 7. Global Gene Therapy for Ovarian Cancer Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Gene Therapy for Ovarian Cancer Market Share by Application: 2024 VS 2031

Figure 9. Ovarian Cancer (Unspecified) Case Studies

Figure 10. Recurrent Ovarian Epithelial Cancer Case Studies

Figure 11. Platinum-Resistant Ovarian Cancer Case Studies

Figure 12. Gene Therapy for Ovarian Cancer Report Years Considered

Figure 13. Global Gene Therapy for Ovarian Cancer Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Gene Therapy for Ovarian Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Gene Therapy for Ovarian Cancer Market Share by Region: 2024 VS 2031

Figure 16. Global Gene Therapy for Ovarian Cancer Market Share by Players in 2024

Figure 17. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Gene Therapy for Ovarian Cancer Revenue in 2024

Figure 19. North America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Gene Therapy for Ovarian Cancer Market Share by Country (2020-2031)

Figure 21. United States Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Gene Therapy for Ovarian Cancer Market Share by Country (2020-2031)

Figure 25. Germany Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Gene Therapy for Ovarian Cancer Market Share by Region (2020-2031)

Figure 33. China Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Gene Therapy for Ovarian Cancer Market Share by Country (2020-2031)

Figure 41. Mexico Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Gene Therapy for Ovarian Cancer Market Share by Country (2020-2031)

Figure 45. Turkey Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Gene Therapy for Ovarian Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Takara Bio Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2020-2025)

Figure 49. VBL Therapeutics Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2020-2025)

Figure 50. CELSION Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2020-2025)

Figure 51. Targovax Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2020-2025)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions